Cassava Sciences Inc (NASDAQ: SAVA) shares soared 29.47%, or $26.77 per share, to close Wednesday at $117.60. After opening the day at $94.58, shares of Cassava fluctuated between $120.75 and $94.30. 9,271,038 shares traded hands an increase from their 30 day average of 3,042,115. Wednesday’s activity brought Cassava’s market cap to $4,705,017,710.
Cassava is headquartered in Austin, Texas..
About Cassava Sciences Inc
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease.